Ira Seth Winer MD PhD

Gynecologic Oncology

Gynecologic Oncology, Karmanos Cancer Institute Professor, Wayne State University

3577 W 13 Mile RdSte 302Royal Oak, MI 48073
Phone+1 248-551-1330

Dr. Winer is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Winer's full profile Already have an account?

Summary

Meet Dr. Ira S. Winer - Gynecologic Oncology

Ira S. Winer, M.D., Ph.D., member of the Gynecologic Oncology Multidisciplinary Team at the Barbara Ann Karmanos Cancer Institute.

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Gynecologic Oncology, 2011 - 2015
University of MichiganResidency, Obstetrics and Gynecology, 2007 - 2011
University of Michigan Medical SchoolClass of 2007
University of MichiganPhD, The Cellular and Molecular Biology Program, 2001 - 2005
Boston UniversityBA, Biochemistry, Molecular Biology, Summa Cum Laude, 1999

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MI State Medical License 2011 - 2027
OH State Medical License 2010 - 2011
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CCITLA award NCI, 2019-2020
1st Prize in Fellow Research Section ACOG Research, 2012
Distinction in Research University of Michigan Medical School, 2007

Clinical Trials

Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer Start of enrollment: 2015 Feb 15
COMPLETED
PHASE1, PHASE2
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
COMPLETED
PHASE1
Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer Start of enrollment: 2019 Sep 18
ACTIVE_NOT_RECRUITING
PHASE1

Publications & Presentations

PubMed

Safety and feasibility of concomitant urogynecologic and gynecologic oncology surgical procedures.
Kyle Wohlrab, Katina Robison, David D Rahn, Gena C Dunivan, John Occhino
Gynecologic Oncology. 2026-02-01
1 citations
Safety and Feasibility of Concomitant Urogynecologic and Gynecologic Oncology Surgical Procedures.
Kyle Wohlrab, Katina Robison, David D Rahn, Gena C Dunivan, John Occhino
Urogynecology. 2026-02-01
1 citations
Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement.
Charles A Powell, Ira S Winer, Christopher M Tarney, Stéphanie Gaillard, Róisín E O'Cearbhaill
Gynecologic Oncology. 2025-11-01

Journal Articles

Merkel cell carcinoma in a patient with noninvasive vulvar Paget's disease
Winer IS, Lonardo F, Johnson SC, Deppe G., Am J Obstet Gynecol, 3/30/2013
Chemotherapy of vulvar cancer: A Review
Deppe G, Mert I, Belotte J, WinerIS, Wien KlinWochenschr, 3/1/2013
Clinical and Pathologic Characteristics of Serous Carcinoma Confined to the Endometrium: A Multi-institutional Study
Seeman A, Mert I, Munkarah A, Bandyopadhyay S, Winer I, et al., Int J GynecolPathol, 3/1/2013

Books/Book Chapters

Know Thy Place
Chapter: Jonathan Adams Allen
Winer IAnn Arbor: University of Michigan Press2000

Abstracts/Posters

The significance of squamous vs. adenocarcinoma subtypes in early stage cervical carcinoma
Winer I, Alvarado-Cabrero I, Seward S, Valencia-Cedillo R, Munkarah A, Ali-Fehmi R., American Association of Cancer Research Annual Meeting, 4/1/2013
A multi-institutional clinic-pathologic study of USC without myometrial invasion
Winer I, Semaan A,Mert I, Hayek K, Bandyopadhyay S, Nucci MR, Van de Vijver KK, Hussein Y, Alosh B, Oliva E, Ali-Fehmi R, International Gynecologic Cancer Society (IGCS),, 10/1/2012
Activation of the unfolded protein response (UPR) by disulfiram in ovarian cancer cells: A novel therapeutic mechanism to overcome chemoresistance
Winer et al., International Journal of Gynecological Cancer, 10/1/2012

Press Mentions

Karmanos Multiple Myeloma Expert Graces Hour Detroit’s 2025 Top Docs Cover, List Includes Over 80 Karmanos PhysiciansOctober 1st, 2025
Big Phase 3 Wins in Lung Cancer and More: Antibody-Drug Conjugate News Rapid RoundupJune 26th, 2025
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 TrialJune 2nd, 2025